Real-world efficacy and safety of Ledipasvir plus Sofosbuvir and Ombitasvir/Paritaprevir/Ritonavir +/- Dasabuvir combination therapies for chronic hepatitis C: A Turkish experience
TURKISH JOURNAL OF GASTROENTEROLOGY, vol.31, no.12, pp.883-893, 2020 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 31 Issue: 12
- Publication Date: 2020
- Doi Number: 10.5152/tjg.2020.20696
- Journal Name: TURKISH JOURNAL OF GASTROENTEROLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
- Page Numbers: pp.883-893
- Karadeniz Technical University Affiliated: Yes
Abstract
Background/Aims: This study aimed to evaluate the real-life efficacy and tolerability of direct-acting antiviral treatments for patients with chronic hepatitis C (CHC) with/without cirrhosis in the Turkish population.